July - 2020
| Previous Next | Showing Journal 4 of 5 |
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and MortalityFosbel, J Butt, L Ostergaard, et al JAMA, 2020, 324(2):168-177 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
July |
Previous Comments
No Comments yet.
Comment
Are angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin receptor blockers (ARBs) associated with worse outcomes in patients with coronavirus disease 2019 (COVID-19) through upregulation of the functional receptor of the virus, ACE...